By Drug Target Review2024-04-04T15:00:03
The compound 11c demonstrates an excellent safety profile and is an exciting advancement in liver disease management.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-05-30T13:51:56
Sponsored by BPS Bioscience
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
Site powered by Webvision Cloud